awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37982433-83A271CC-7932-4D3D-BBAB-7BF5F4F21F8C
Q37982433-83A271CC-7932-4D3D-BBAB-7BF5F4F21F8C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37982433-83A271CC-7932-4D3D-BBAB-7BF5F4F21F8C
Pertuzumab: in the first-line treatment of HER2-positive metastatic breast cancer.
P2860
Q37982433-83A271CC-7932-4D3D-BBAB-7BF5F4F21F8C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37982433-83A271CC-7932-4D3D-BBAB-7BF5F4F21F8C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e59487af9b59db4d91190eceb7b96ce6be0975cf
P2860
A phase Ib study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumours.